Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane; Single-pass type I membrane protein. |
Domain |
PF00028 Cadherin domain PF01049 Cadherin cytoplasmic region |
Function |
Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
Biological Process |
GO:0007156 homophilic cell adhesion via plasma membrane adhesion molecules GO:0034330 cell junction organization GO:0034332 adherens junction organization GO:0045216 cell-cell junction organization GO:0098742 cell-cell adhesion via plasma-membrane adhesion molecules |
Molecular Function | - |
Cellular Component | - |
KEGG | - |
Reactome |
R-HSA-418990: Adherens junctions interactions R-HSA-446728: Cell junction organization R-HSA-1500931: Cell-Cell communication R-HSA-421270: Cell-cell junction organization |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between CDH18 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of CDH18 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of CDH18 in various data sets.
|
Points in the above scatter plot represent the mutation difference of CDH18 in various data sets.
|
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of CDH18. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of CDH18. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by CDH18. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of CDH18. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of CDH18 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | CDH18 |
Name | cadherin 18, type 2 |
Aliases | EY-CADHERIN; CDH14L; Cadherin-18 |
Chromosomal Location | 5p14.3 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between CDH18 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |